Company Analysis
Sign in

Pulsenmore Ltd. (PLSM)

Nasdaq: PLSM · Surgical & Medical Instruments & Apparatus · filing with the SEC since 2025
Full chart Alerts Compare
Grade6.5
◀ Past 7.8● Present 6.3▶ Future 5.3
3 est.
OverviewBusinessFinancialsGradeForecastSentimentOwnershipPeopleFilingsPatents Chart
The companyfiscal 2025, as filed
Revenue₪40.0M+314.3%
Net income-₪15.9M+56.8%
Earnings per share₪2.46-57.3%
Operating cash flow-₪32.9M+20.7%
Cash₪21.6M-47.5%
Debtn/a
Shareholders’ equity₪83.1M-14.2%
Shares, diluted6,442,805+0.6%
Return on equity-19.1%
The recordfrom its filings
Filings in 202646
Newest filingNov 5 · 4
Annual reportMar 30, 2026
Quarterly reportn/a
Next report due20-F by Apr 30
Insider sales, 12 months$0.00
Insider buys, 12 months$0.00
Patents granted6
Filer categoryNon-accelerated filer<br>Emerging growth company
Left: the newest annual report, with the change on the year before. Right: counted from the company's own filings with the SEC.
Revenue and net income by fiscal yearRevenueNet income
232425
As filed, in ILS. Nothing here is a forecast.

News

Nov 5, 2026 · SEC EDGAR · Form 4
Insider trade report
Open the filing on sec.gov
Oct 21, 2026 · SEC EDGAR · Form 4
Insider trade report
Open the filing on sec.gov
Oct 14, 2026 · SEC EDGAR · Form 4
Insider trade report
Open the filing on sec.gov
Oct 8, 2026 · SEC EDGAR · Form SCHEDULE 13G
Large holder notice
Open the filing on sec.gov
Sep 1, 2026 · SEC EDGAR · Form EFFECT
Registration effective
Open the filing on sec.gov
An outside story is shown by its headline, its source and its link only. The SI reads the page when you ask it to break one down.
SI Assistanton PLSM · research, not advice